The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis

The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis

IntroductionAs a form of precision medicine, this study aimed to investigate the specific patient population that would derive the greatest benefit from tildrakizumab, as well as the mechanism of action and efficacy of tildrakizumab in reducing the occurrence of psoriatic arthritis (PsA).MethodsTo a...

Full description

Bibliographic Details
Main Authors: Takemichi Fukasawa, Takashi Yamashita, Atsushi Enomoto, Yuta Norimatsu, Satoshi Toyama, Asako Yoshizaki-Ogawa, Shoko Tateishi, Hiroko Kanda, Kiyoshi Miyagawa, Shinichi Sato, Ayumi Yoshizaki
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
psoriasis
psoriatic arthritis
nailfold capillary
risk factors
tildrakizumab
regulatory T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1286251/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1286251/full

Similar Items